IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q2 2019 Holdings

Filed 2019-08-14 | 15 holdings | $4.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Caredx Inc(CDNA)COM14167L103$4.7M129,85597.7%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$13.0K70,8490.3%
Merck & Co Inc(MRK)COM58933Y105$11.8K141,0000.2%
Bristol Myers Squibb Co(BMY)COM110122108$11.0K242,9370.2%
Humana Inc(HUM)COM444859102$10.9K41,0000.2%
Thermo Fisher Scientific Inc(TMO)COM883556102$10.6K35,9760.2%
Illumina Inc(ILMN)COM452327109$10.1K27,3160.2%
Gilead Sciences Inc(GILD)COM375558103$10.0K147,9160.2%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$5.9K11,2010.1%
Zoetis Inc(ZTS)CL A98978V103$5.7K50,3750.1%
Sarepta Therapeutics Inc(SRPT)COM803607100$4.6K30,0000.1%
Iqvia Hldgs Inc(IQV)COM46266C105$4.2K25,9860.1%
Amicus Therapeutics Inc(FOLD)COM03152W109$4.1K325,0000.1%
Stryker Corp(SYK)COM863667101$3.8K18,5970.1%
Sientra IncCOM82621J105$2.2K360,0000.0%